Tadalafil Tablet, Film Coated
Product Images NDC 68071-3929

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Tadalafil (NDC 68071-3929). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceutical,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3929 3)

FDA Label Image

Camber1jpj (Camber1jpg)

FDA Label Image

Tadalafilfigure1.jpg (Tadalafilfigure1)

This is a comparison of differences in blood pressure measurements in different positions such as standing and supine. The text seems to be discussing the change in blood pressure levels between the drug "Tadlai" and placebo. The data appears to include measurements for systolic and diastolic blood pressure in both standing and supine positions.*

FDA Label Image

Tadalafilfigure2.jpg (Tadalafilfigure2)

This text provides information regarding a study involving Tadalafil 20 mg and doxazosin 8 mg, as well as a placebo and doxazosin 8 mg. The numbers listed at the bottom may indicate time points or dosage levels for the study.*

FDA Label Image

Tadalafilfigure4.jpg (Tadalafilfigure4)

FDA Label Image

Tadalafilfigure5.jpg (Tadalafilfigure5)

FDA Label Image

Tadalfilfigure6.jpg (Tadalafilfigure6)

FDA Label Image

Tadalafilfigure7.jpg (Tadalafilfigure7)

FDA Label Image

Tadalafilfigure8 (Tadalafilfigure8)

FDA Label Image

Tadalfilfigure9.jpg (Tadalafilfigure9)

FDA Label Image

Tadalafilstructure.jpg (Tadalafilstructure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.